Hematology NewsCAR T-cell therapy: Moving from cost to valueNovember 21, 2017ALLAggressive LymphomasImmuno-oncology
Hematology TimesNilotinib approved to treat kids with CML in EUNovember 21, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Hematology TimesCD22-CAR therapy shows activity in rel/ref B-ALLNovember 21, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology NewsStart with fitness when deciding on treatment for elderly AML patientsNovember 20, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsCyclophosphamide after transplant reduced GVHD in myeloma patientsNovember 20, 2017Multiple MyelomaCellular TherapyLymphoma & Plasma Cell Disorders
Oncology PracticeMACRA Monday: Elder maltreatment screeningNovember 20, 2017Business of MedicinePractice Management
Oncology PracticeSquamous cell carcinoma linked to 25% increase in all-cause mortalityNovember 18, 2017Nonmelanoma Skin Cancer
Hematology NewsStudies need to address best follow-on therapy to ibrutinib in CLLNovember 18, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsFDA approves first-in-class drug for hemophilia A with Factor VIIINovember 18, 2017Bleeding Disorders